Specific allelic variants of SNPs in the MDM2 and MDMX genes are associated with earlier tumor onset and progression in Caucasian breast cancer patients

Autor: Jutta John, Katharina Politt, Thorsten Stiewe, Edith Weigert, Eva Johanna Kantelhardt, Frank Bartel, T Lantzsch, Christoph Thomssen, Claudia Wickenhauser, Christoph Uleer, Jörg Buchmann, Susanne Peschel, Volker Hanf, Karl-Friedrich Bürrig, Martina Vetter, Marco Mernberger, Andrea Nist, Marcus Bauer
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Zdroj: Oncotarget
ISSN: 1949-2553
Popis: // Marcus Bauer 1 , Eva Johanna Kantelhardt 2, 3 , Thorsten Stiewe 4, 5, 6 , Andrea Nist 4 , Marco Mernberger 4 , Katharina Politt 4 , Volker Hanf 7 , Tilmann Lantzsch 8 , Christoph Uleer 9 , Susanne Peschel 10 , Jutta John 11 , Jorg Buchmann 12 , Edith Weigert 13 , Karl-Friedrich Burrig 14 , Claudia Wickenhauser 1 , Christoph Thomssen 2 , Frank Bartel 1, * and Martina Vetter 2, * 1 Institute of Pathology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany 2 Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany 3 Institute of Medical Epidemiology, Biostatistics and Informatics, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany 4 Institute of Molecular Oncology, Universities of Giessen and Marburg Lung Center, German Center for Lung Research (DZL), Marburg, Germany 5 Genomics Core Facility, Philipps-University, Universities of Giessen and Marburg Lung Center, German Center for Lung Research (DZL), Marburg, Germany 6 Universities of Giessen and Marburg Lung Center, German Center for Lung Research (DZL), Marburg, Germany 7 Department of Gynaecology, Hospital Fuerth, Fuerth, Germany 8 Department of Gynaecology, Hospital St. Elisabeth and St. Barbara, Halle (Saale), Germany 9 Onkologische Praxis Uleer, Hildesheim, Germany 10 Department of Gynaecology, St. Bernward Hospital, Hildesheim, Germany 11 Department of Gynaecology, Helios Hospital Hildesheim, Hildesheim, Germany 12 Institute of Pathology, Hospital Martha-Maria, Halle (Saale), Germany 13 Institute of Pathology, Hospital Fuerth, Fuerth, Germany 14 Institute of Pathology Hildesheim, Hildesheim, Germany * Co-senior authors and contributed equally to this work Correspondence to: Frank Bartel, email: frank.bartel@medizin.uni-halle.de Keywords: p53; mutation; tumor suppression; breast cancer; single nucleotide polymorphism Received: September 18, 2018 Accepted: February 15, 2019 Published: March 08, 2019 ABSTRACT Background: Genetic factors play a substantial role in breast cancer etiology. Genes encoding proteins that have key functions in the DNA damage response, such as p53 and its inhibitors MDM2 and MDMX, are most likely candidates to harbor allelic variants that influence breast cancer susceptibility. The aim of our study was to comprehensively analyze the impact of SNPs in the TP53 , MDM2 , and MDMX genes in conjunction with TP53 mutational status regarding the onset and progression of breast cancer. Methods: In specimen from 815 breast cancer patients, five SNPs within the selected genes were analyzed: TP53 – Arg72Pro (rs1042522), MDM2 – SNP285 (rs2279744), SNP309 (rs117039649); MDMX – SNP31826 (rs1563828), and SNP34091 (rs4245739). Classification of the tumors was evaluated by histomorphology. Subtyping according hormone receptor status, HER2-status and proliferation rate enabled provision of the clinico-pathological surrogate of intrinsic subtypes. Results: The homozygous C-allele of MDM2 SNP285 was significantly associated with a younger age-at-diagnosis of 44.2 years, in contrast to G/G- and G/C-patients (62.4, 62.7 yrs., respectively; p = 0.0007; log-Rank-test). In contrast, there was no difference regarding the age-at-diagnosis for patients with the respective genotypes of MDM2 SNP309 ( p = 0.799; log-Rank-test). In patients with estrogen receptor (ER)-positive and TP53 -mutated tumors, however, the T/T-genotype of the MDM2 SNP309 was significantly associated with an earlier average age-at-diagnosis compared with T/G+G/G-patients (53.5 vs. 68.2 yrs; p = 0.002; log-Rank-test). In the triple-negative subgroup, the G/G-patients had an average age-at-diagnosis of 51 years compared with 63 years for SNP309T carriers ( p = 0.004; log-Rank-test) indicating a susceptibility of the G/G genotype for the development of triple negative breast cancer. Patients with the A/A-genotype of MDMX SNP31826 with ER-negative tumors were diagnosed 11 years earlier compared with patients and ER-positive tumors (53.2 vs. 64.4 yrs; p = 0.025, log-Rank-test). Furthermore, in luminal B-like patients (HER2-independent) the C/C-genotype of MDMX SNP34091 was significantly correlated with a decreased event-free survival compared with the A/A-genotype ( p < 0.001; log-Rank-test). Conclusions: We showed that SNPs in the MDM2 and MDMX genes affect at least in part the onset and progression of breast cancer dependent on the ER-status. Our findings provide further evidence for the distinct etiological pathways in ER-negative and ER-positive breast cancers.
Databáze: OpenAIRE
Externí odkaz: